Fig. 2: Adverse events in adolescents after administration of a first or second dose of MVC-COV1901.
Solicited local (A) and systemic (B) adverse events were graded as mild (grade 1), moderate (grade 2), or severe (grade 3).
Fig. 2: Adverse events in adolescents after administration of a first or second dose of MVC-COV1901. | npj Vaccines
